Results 151 to 160 of about 4,087 (214)

Psychedelic therapy and postpartum depression: priorities and prospects. [PDF]

Ther Adv Psychopharmacol
Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR.   +7 more
europepmc   +1 more source

Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users. [PDF]

Psychopharmacology (Berl)
David J, Berkovich-Ohana A, Dor-Ziderman Y.   +2 more
europepmc   +1 more source

Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]

Cell Rep Med
Avram M, Borgwardt S.
europepmc   +1 more source

What fMRI studies say about the nature of the psychedelic effect: a scoping review. [PDF]

Front Neurosci
Beneš M, Páleníček T, Horáček J.
europepmc   +1 more source

Exploring Colombian medicinal flora used in indigenous and campesino health systems for neuropsychiatric disorders and neuropharmacological potential: an ethnopharmacological review. [PDF]

Front Pharmacol
Brache K, Diazgranados M.
europepmc   +1 more source

Psychedelic therapy and cultural humility. [PDF]

Transl Psychiatry
Gearin A, Docherty J, Sun X, Cheung EH, Tanuseputro P.   +4 more
europepmc   +1 more source

Reported Safety Practices of Publicly Advertised Psychedelic Retreats.

JAMA Netw Open
McGuire AL, Neitzke-Spruill L, Robinson JO, Beit CS, Singh N, Mathai DS, Averill LA.   +6 more
europepmc   +1 more source

Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review. [PDF]

Cureus
Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J.   +9 more
europepmc   +1 more source

Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. [PDF]

J Clin Med
Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ.   +4 more
europepmc   +1 more source